Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biopharma, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation, effective April 1, 2023.
read more
Rentschler Biopharma SE announced the appointment of Robert Panting, Ph.D., to the newly created position of Vice President Global Client Program Management (CPM) and Strategy, effective immediately.
read more
Rentschler Biopharma SE announced that Patrick Meyer, Ph.D., has been promoted to Global Head BD Sales and Alliance Management within the business development team, effective June 1, 2024. In this newly created position, Dr. Meyer will oversee global...
read more
Tuesday, September 19, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has hired Benedikt von Braunmuehl as Chief Executive Officer (CEO).
read more
Tuesday, February 25, 2025
Rentschler Biopharma SE announced the promotion of Patrick Meyer, Ph.D., to Global Head of Business Development (BD), effective immediately.
read more
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Martin Kessler as Chief Executive Officer (CEO) of Rentschler Biopharma Inc., the ...
read more
Friday, November 03, 2023
Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced the promotion of Dr. Björn Beckmann to the position of Head of Quality Control at the Company's Laupheim site in ...
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Robert Panting as General Manager of Rentschler ATMP[*] Ltd. This center of excellence is...
read more
Thursday, October 24, 2024
Rentschler Biopharma SE announced the construction of a new state-of-the-art buffer media station at its company headquarters in Laupheim.
read more
Wednesday, December 26, 2018
Rentschler Biopharma announced Henning Gerschewski will join the company as Vice President Manufacturing Science and Technology, effective January 1, 2019.
read more
Wednesday, February 28, 2018
Rentschler Biopharma SE announced that Federico Pollano has joined the company as Senior Vice President, Business Development, effective March 1, 2018.
read more
Tuesday, February 06, 2024
Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that Senta Brandt has been promoted to the global position of Head of ...
read more
Rentschler Biopharma SE will further develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation.
read more
Thursday, December 13, 2018
Rentschler Biopharma announced Dr. Jesús Zurdo will join the company as Senior Vice President Process Science and Innovation, effective January 01, 2019.
read more
Wednesday, November 06, 2019
Rentschler Biopharma SE is taking the first step in the expansion project to grow its U.S. footprint and establish a Center of Excellence in North America.
read more